The startup company Vesigen will develop and commercialize the drug-delivery technology created in the lab of Harvard Chan School Professor Quan Lu.
July 22, 2020 • ~10 min
Tags: science-technology harvard-th-chan-school-of-public-health office-of-technology-development quan-lu caroline-perry armms arrdc1-mediated-microvesicles blavatnik-biomedical-accesserator large-molecule-drugs vesigen-therapeutics
Harvard stem-cell research receives support from Sarepta Therapeutics for work on Duchenne muscular dystrophy.
Jan. 9, 2020 • ~6 min
Tags: science-technology stem-cells office-of-technology-development amy-wagers caroline-perry duchenne-muscular-dystrophy sarepta-therapeutics
Page 1 of 1